As of 2025-10-16, the Relative Valuation of Pacira Biosciences Inc (PCRX) is (80.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.45 USD, the upside of Pacira Biosciences Inc based on Relative Valuation is -443.6%.
The range of the Relative Valuation is (83.29) - (88.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.4x - 36.9x | 31.4x |
| Forward P/E multiples | 20.5x - 31.2x | 25.4x |
| Fair Price | (83.29) - (88.45) | (80.57) |
| Upside | -455.2% - -477.2% | -443.6% |
| Date | P/E |
| 2025-10-14 | -8.01 |
| 2025-10-13 | -7.85 |
| 2025-10-10 | -7.88 |
| 2025-10-09 | -8.13 |
| 2025-10-08 | -8.25 |
| 2025-10-07 | -8.33 |
| 2025-10-06 | -8.41 |
| 2025-10-03 | -8.76 |
| 2025-10-02 | -8.66 |
| 2025-10-01 | -8.91 |
| 2025-09-30 | -9.08 |
| 2025-09-29 | -8.93 |
| 2025-09-26 | -8.90 |
| 2025-09-25 | -9.04 |
| 2025-09-24 | -9.18 |
| 2025-09-23 | -9.24 |
| 2025-09-22 | -9.33 |
| 2025-09-19 | -9.40 |
| 2025-09-18 | -9.39 |
| 2025-09-17 | -9.19 |
| 2025-09-16 | -9.34 |
| 2025-09-15 | -9.47 |
| 2025-09-12 | -9.56 |
| 2025-09-11 | -9.53 |
| 2025-09-10 | -9.38 |
| 2025-09-09 | -9.27 |
| 2025-09-08 | -9.43 |
| 2025-09-05 | -9.32 |
| 2025-09-04 | -9.42 |
| 2025-09-03 | -9.58 |
| 2025-09-02 | -9.60 |
| 2025-08-29 | -9.40 |
| 2025-08-28 | -9.46 |
| 2025-08-27 | -9.21 |
| 2025-08-26 | -9.16 |
| 2025-08-25 | -8.94 |
| 2025-08-22 | -9.11 |
| 2025-08-21 | -8.95 |
| 2025-08-20 | -8.81 |
| 2025-08-19 | -8.88 |
| 2025-08-18 | -8.77 |
| 2025-08-15 | -8.74 |
| 2025-08-14 | -8.81 |
| 2025-08-13 | -8.83 |
| 2025-08-12 | -8.75 |
| 2025-08-11 | -8.88 |
| 2025-08-08 | -8.88 |
| 2025-08-07 | -8.38 |
| 2025-08-06 | -7.90 |
| 2025-08-05 | -7.95 |